404
Glucose Monitoring System Market Report
Glucose Monitoring System Market Trends, Dynamcis & Market Insights
Glucose Monitoring System Market, By Type (Sensors, Transmitters & Receivers, Integrated Insulin Pumps), End-User (Hospitals, Clinics, Home Healthcare), and Region - COVID-19 Impact Analysis and Forecast to 2026.
The glucose monitoring system market is expected to witness an impressive growth of 6.1% CAGR in the coming years.
Medtronic plc (Ireland), Abbott Laboratories (US), DexCom, Inc. (US), Echo Therapeutics Inc. (US), Insulet Corporation (US), Johnson & Johnson (US), Senseonics Holdings, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), AgaMatrix Inc. (Germany), Glysure Ltd (UK), ORSENSE LTD (Israel) and Ypsomed (Switzerland) are among the key players in the glucose monitoring system market.
The glucose monitoring system market size is expected to reach USD 2.7 billion in the foreseeable future.
The hospitals' segment is expected to register significant growth in the glucose monitoring system market in the coming years.
North America accounted for the largest share in the glucose monitoring system market in the coming years.
Glucose monitoring system distributors, Glucose monitoring system suppliers, Glucose monitoring system manufacturers, Logistics organizations, Government bodies are the target audience in the glucose monitoring system market.